Appointment of Mr. Mayur Desai (DIN: 00358846) as an Additional Director (Non- Executive Independent) w.e.f. 11th November, 2025 for a term of 5 consecutive years, subject to the approval ....
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries' board met on 11th November 2025 and approved the unaudited standalone and consolidated financial results for Q2 and H1 FY26 (ended 30 September 2025). Standalone revenue from operations for the quarter stood at ₹8,397.60 lakhs, up from ₹5,984.95 lakhs in Q1 FY26, while half-yearly revenue was ₹14,382.55 lakhs versus ₹16,722.18 lakhs in H1 FY25, a decline of about 14%. Net profit after tax for the quarter was ₹443.06 lakhs and ₹867.23 lakhs for the half year, with EPS of ₹0.87 and ₹1.70 respectively. The board also approved the appointment of Mr. Mayur Desai (Chartered Accountant with 40+ years of experience in tax, advisory and governance) as an Additional Non-Executive Independent Director for a 5-year term, subject to shareholder approval via postal ballot. The results also reflect the classification of the company's Japan-based wholly-owned subsidiary, B.R. Chemicals Co. Ltd., as discontinued operations as the board moves toward selling or closing it.
Revenue and profits are clearly down compared to the same period last year, which may weigh on the stock in the short term, though the quarterly recovery from Q1 is a positive sign. The addition of a seasoned independent director strengthens board governance, and the ongoing move to exit the loss-making Japanese subsidiary could improve future profitability.